Suppr超能文献

翻译起始需要细胞分裂周期蛋白 123(Cdc123)来促进真核起始因子 2(eIF2)的生物发生。

Translation initiation requires cell division cycle 123 (Cdc123) to facilitate biogenesis of the eukaryotic initiation factor 2 (eIF2).

机构信息

Department of Genetics, University of Regensburg, D-93040 Regensburg, Germany.

出版信息

J Biol Chem. 2013 Jul 26;288(30):21537-46. doi: 10.1074/jbc.M113.472290. Epub 2013 Jun 17.

Abstract

The eukaryotic translation initiation factor 2 (eIF2) is central to the onset of protein synthesis and its modulation in response to physiological demands. eIF2, a heterotrimeric G-protein, is activated by guanine nucleotide exchange to deliver the initiator methionyl-tRNA to the ribosome. Here we report that assembly of the eIF2 complex in vivo depends on Cdc123, a cell proliferation protein conserved among eukaryotes. Mutations of CDC123 in budding yeast reduced the association of eIF2 subunits, diminished polysome levels, and increased GCN4 expression indicating that Cdc123 is critical for eIF2 activity. Cdc123 bound the unassembled eIF2γ subunit, but not the eIF2 complex, and the C-terminal domain III region of eIF2γ was both necessary and sufficient for Cdc123 binding. Alterations of the binding site revealed a strict correlation between Cdc123 binding, the biological function of eIF2γ, and its ability to assemble with eIF2α and eIF2β. Interestingly, high levels of Cdc123 neutralized the assembly defect and restored the biological function of an eIF2γ mutant. Moreover, the combined overexpression of eIF2 subunits rescued an otherwise inviable cdc123 deletion mutant. Thus, Cdc123 is a specific eIF2 assembly factor indispensable for the onset of protein synthesis. Human Cdc123 is encoded by a disease risk locus, and, therefore, eIF2 biogenesis control by Cdc123 may prove relevant for normal cell physiology and human health. This work identifies a novel step in the eukaryotic translation initiation pathway and assigns a biochemical function to a protein that is essential for growth and viability of eukaryotic cells.

摘要

真核翻译起始因子 2(eIF2)是蛋白质合成起始及其对生理需求的调节的核心。eIF2 是一种异源三聚体 G 蛋白,通过鸟嘌呤核苷酸交换被激活,将起始甲硫氨酸-tRNA 递送到核糖体。在这里,我们报告说,体内 eIF2 复合物的组装依赖于细胞增殖蛋白 Cdc123,该蛋白在真核生物中保守。芽殖酵母中 CDC123 的突变减少了 eIF2 亚基的结合,降低了多核糖体水平,并增加了 GCN4 的表达,表明 Cdc123 对 eIF2 活性至关重要。Cdc123 结合未组装的 eIF2γ 亚基,但不结合 eIF2 复合物,并且 eIF2γ 的 C 端结构域 III 区域对于 Cdc123 结合既是必需的又是充分的。结合位点的改变揭示了 Cdc123 结合、eIF2γ 的生物学功能及其与 eIF2α 和 eIF2β 组装之间的严格相关性。有趣的是,高水平的 Cdc123 中和了组装缺陷并恢复了 eIF2γ 突变体的生物学功能。此外,eIF2 亚基的联合过表达挽救了 otherwise inviable cdc123 缺失突变体。因此,Cdc123 是一种特定的 eIF2 组装因子,对于蛋白质合成的起始是必不可少的。人类 Cdc123 由疾病风险基因座编码,因此,Cdc123 对 eIF2 生物发生的控制可能与正常细胞生理学和人类健康有关。这项工作确定了真核翻译起始途径中的一个新步骤,并赋予了一种对真核细胞生长和存活至关重要的蛋白质生化功能。

相似文献

2
7
Binding of human Cdc123 to eIF2γ.人 Cdc123 与 eIF2γ 的结合。
J Struct Biol. 2023 Sep;215(3):108006. doi: 10.1016/j.jsb.2023.108006. Epub 2023 Jul 27.

引用本文的文献

7
8
Pharmacological targeting of endoplasmic reticulum stress in disease.内质网应激在疾病中的药理学靶向治疗。
Nat Rev Drug Discov. 2022 Feb;21(2):115-140. doi: 10.1038/s41573-021-00320-3. Epub 2021 Oct 26.
9
Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB.小分子ISRIB对eIF2中MEHMO综合征突变的抑制作用
Mol Cell. 2020 Feb 20;77(4):875-886.e7. doi: 10.1016/j.molcel.2019.11.008. Epub 2019 Dec 10.

本文引用的文献

3
6
Systematic and quantitative assessment of the ubiquitin-modified proteome.系统且定量的泛素化蛋白质组学研究。
Mol Cell. 2011 Oct 21;44(2):325-40. doi: 10.1016/j.molcel.2011.08.025. Epub 2011 Sep 8.
7
Molecular mechanism of scanning and start codon selection in eukaryotes.真核生物扫描和起始密码子选择的分子机制。
Microbiol Mol Biol Rev. 2011 Sep;75(3):434-67, first page of table of contents. doi: 10.1128/MMBR.00008-11.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验